Trade ANIK anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Anika Therapeutics Inc. (ANIK) is trading at US$21.29, up 2.16% today as of Aug 28, 12:58 EDT. The company has a market capitalisation of US$291.48M. Over the past 52 weeks, ANIK has traded between US$8.37 and US$22.88. On Syfe you can trade ANIK with $0 commission and add it to your watchlist.
| Previous close | US$20.84 |
|---|---|
| Market cap | US$291.48M |
| P/E ratio | 32.02 |
| 52-week range | US$8.37 – US$22.88 |
| Volume | 171.4K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Anika Therapeutics Inc.
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Year: 1993
Anika Therapeutics Inc. (ANIK) stock is trading at US$21.29, +2.16% from the previous close of US$20.84.
The market cap for Anika Therapeutics Inc. (ANIK) stock is approximately US$291.48M.
The price-to-earnings ratio for Anika Therapeutics Inc. (ANIK) is 32.02, based on the latest reported earnings.
The 52-week high for Anika Therapeutics Inc. (ANIK) stock is US$22.88.
The 52-week low for Anika Therapeutics Inc. (ANIK) stock is US$8.37.
Anika Therapeutics Inc. (ANIK) does not currently pay a dividend.
Stay on top of ANIK
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
